These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19250191)

  • 1. 5alpha-reductase isozymes and androgen actions in the prostate.
    Zhu YS; Imperato-McGinley JL
    Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a quantitative RT-PCR method to study 5alpha-reductase mRNA isozymes in rat prostate in different androgen status.
    Torres JM; Ruiz E; Ortega E
    Prostate; 2003 Jun; 56(1):74-9. PubMed ID: 12746849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer.
    Titus MA; Gregory CW; Ford OH; Schell MJ; Maygarden SJ; Mohler JL
    Clin Cancer Res; 2005 Jun; 11(12):4365-71. PubMed ID: 15958619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sulpiride on mRNA levels of steroid 5alpha-reductase isozymes in prostate of adult rats.
    Sánchez P; Torres JM; Vílchez P; Del Moral RG; Ortega E
    IUBMB Life; 2008 Jan; 60(1):68-72. PubMed ID: 18379994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition.
    Henderson NA; Cooke GM; Robaire B
    J Endocrinol; 2006 Sep; 190(3):779-91. PubMed ID: 17003279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ androgen producing enzymes in human prostate cancer.
    Nakamura Y; Suzuki T; Nakabayashi M; Endoh M; Sakamoto K; Mikami Y; Moriya T; Ito A; Takahashi S; Yamada S; Arai Y; Sasano H
    Endocr Relat Cancer; 2005 Mar; 12(1):101-7. PubMed ID: 15788642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of type I and type II 5alpha-reductase isoenzymes in prostate cancer tissues].
    Ye L; Zhang Y; Fang Z
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1504-7. PubMed ID: 16200776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
    Makridakis N; Akalu A; Reichardt JK
    Oncogene; 2004 Sep; 23(44):7399-405. PubMed ID: 15326487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells.
    Zhu YS; Cai LQ; You X; Cordero JJ; Huang Y; Imperato-McGinley J
    J Androl; 2003; 24(5):681-7. PubMed ID: 12954658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview on 5alpha-reductase inhibitors.
    Aggarwal S; Thareja S; Verma A; Bhardwaj TR; Kumar M
    Steroids; 2010 Feb; 75(2):109-53. PubMed ID: 19879888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.
    Pelletier G; Luu-The V; Huang XF; Lapointe H; Labrie F
    J Urol; 1998 Aug; 160(2):577-82. PubMed ID: 9679931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
    Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
    Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid 5alpha-reductase isozymes in the adult female rat brain: central role of dihydrotestosterone.
    Torres JM; Ortega E
    J Mol Endocrinol; 2006 Apr; 36(2):239-45. PubMed ID: 16595696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5alpha-reductase inhibitors.
    Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
    Steroids; 2010 Jun; 75(6):411-8. PubMed ID: 20170668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.
    Thomas LN; Douglas RC; Lazier CB; Too CK; Rittmaster RS; Tindall DJ
    Eur Urol; 2008 Feb; 53(2):244-52. PubMed ID: 18006217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.